CLSI document MA2 (ISBN ). Clinical and Laboratory Standards Institute, West Valley Road, Suite , Wayne, Pennsylvania 15 Aug CLSI M Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Third Edition. Fastidious Organisms: CLSI MA2 update. Diane M. Citron. SWACM, R.M. Alden Research Lab. Culver City, CA. History. ▫ CLSI has provided testing.
|Published (Last):||5 June 2006|
|PDF File Size:||17.33 Mb|
|ePub File Size:||3.11 Mb|
|Price:||Free* [*Free Regsitration Required]|
Developing MA Interpretive Breakpoints. Clinically important drug resistance has been reported for each of these organisms. Clsi m45, data dlsi large clinical trials are generally not available for reassessment of older drugs when new bacterial drug-resistance mechanisms emerge several years after a drug has been introduced into clinical practice. In some parts of the world, fluoroquinolone and macrolide resistance occurs clsi m45 those 2 species, and fluoroquinolone and macrolide resistance is increasing in the United States as well [ 44—46 ].
Granulicatella and Abiotrophia species from human clinical specimens. Summary clsi m45 infrequently isolated or fastidious bacteria included in Clinical and Laboratory Standards Institute document MA [ 50 ] and the suggested media for testing.
Standard: CLSI M45
They were placed on your computer when you launched this website. To establish MIC interpretive criteria or breakpoints for new clsi m45 agents, to modify existing breakpoints, or to establish breakpoints for organisms for which breakpoints have not previously existed, clsi m45 types of data have been required, as outlined in a M4 publication [ 14 ]. The performance, applications, and limitations of the current CLSI-recommended methods are described.
The guidelines provide recommendations for when it may be clsi m45 to test these organisms, how standard methods may be easily adapted for testing, and appropriate interpretive criteria for results.
The only organisms in MA [ 50 ] for which disk diffusion testing with some drugs is recommended at present are Aeromonas, Ples iomonas, Campylobacter, Pasteurellaand Vibrio species table 1. Etiology of implant orthopedic infections: The organisms include Aeromonas species, Bacillus clsi m45, and Vibrio species that may cause infections following environmental exposure.
Broth microdilution MIC cls are described for all of the organisms, incorporating either unsupplemented cation-adjusted Mueller-Hinton broth clsi m45 cation-adjusted Mueller-Hinton broth clsi m45 with 2. In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against gram-positive anaerobic and 31 Corynebacterium clinical isolates.
Thank you for submitting a comment on this article. Not Logged In Member?: Generally, only isolates involved in serious infections would be tested, clsi m45 additional considerations for testing would include 1 persistent infection, 2 clinical failure, 3 allergy to or intolerance of the drugs of choice, and clsi m45 possible resistance to a j45 that might be prescribed. For all clsi m45 included in MA [ 50 ], the testing media, incubation conditions, and quality-control procedures are the same standardized methods as those recommended for testing commonly encountered bacteria in CLSI M2, M7, and M [ 10—12 ]; no exotic test clsi m45 or test formats have been suggested.
Therefore, it is likely that clinical laboratories will be asked to test individual clinical isolates of Campylobacter in the future, and public health laboratories will need to perform surveillance of antimicrobial resistance in human and animal isolates. Host cell DNA methylation markers clsk the detection of high-grade anal intraepithelial neoplasia and anal cancer.
Notable among the Corynebacterium species are Corynebacterium clsi m45 and Corynebacterium urealyticumboth of which have been reported to be multidrug resistant including resistance to penicillins and cephalosporins, macrolides, and aminoglycosides and both of which may cause medical device-related infections [ 17 ].
A case of Leuconostoc ventriculitis with resistance to carbapenem antibiotics. In recent years, the CLSI has found pharmacodynamic determinations to be a useful third parameter to consider in establishing breakpoints.
A variety of laboratory techniques can be used to measure the in vitro susceptibility of bacteria to antimicrobial agents. There are numerous species of Bacillus that can cause wound or ocular infections clsi m45 from traumatic inoculations with soil or water. When these uncommon bacterial clsi m45 are encountered, it may prompt consultation with an infectious diseases specialist for optimal patient management.
As csli other organisms that are indigenous to the skin and mucous membranes, it is imperative to be certain, prior to testing, that a particular isolate among these genera is likely to be clinically significant and not representative clsi m45 contamination or normal flora. Add comment Close clsi m45 form modal. The purpose of this review is to provide the rationale for the development of the new Clinical m455 Laboratory Standards Institute CLSI; formerly the NCCLS guidelines j45 antimicrobial clsi m45 testing of infrequently encountered or fastidious clsi m45.
Please check for further notifications by email. Barth Reller, Melvin P. In vitro activities of a new des-fluoroquinolone, BMSand seven other antimicrobial agents against isolates of Eikenella corrodens. Infections due clwi corynebacteria, lactobacilli, Bacillus species, Leuconostoc species, and Pediococcus species can occur in these circumstances.
The lack of test methods or interpretive criteria for these organisms and the lack of clsi m45 regarding clsi m45 most important drugs for clsi m45 made it clsi m45 to assess the susceptibility of isolates from individual patients and difficult for public health authorities to monitor any emerging clsl resistance.
Resistance clsi m45 uncommon dlsi cocci and rods. These included various coryneform bacteria, Bacillus species other than B. Although Aeromonas, Plesiomonas, Campylobacter, Erysipelothrix, Listeria, Moraxella, Pasteurella, Pediococcusand Vibrio species are more likely to be associated with a pathogenic process, susceptibility testing of these organisms is not always necessary.
These 2 documents are used with a companion document, M [ 12 ], which contains the supplemental tables with drugs recommended for testing and reporting, interpretive breakpoints, and quality-control ranges. Exceptions will occur for Bacillus, Corynebacterium, Lactobacillusand Leuconostoc species that are often considered to be normal flora.
The Alexander Project Group. Comparative in vitro activities of clsk quinolones against coryneform bacteria.
This realization led CLSI to examine the incidence of drug resistance and to pursue clsi m45 of guidelines for antimicrobial susceptibility testing of several infrequently encountered or fastidious bacteria that were not clsi m45 in the previous CLSI documents. They have been reported to have diminished susceptibility to clsi m45, resulting in poorer response to treatment with penicillin in patients with endocarditis [ 30 ]. Clostridium difficile Coinfection Among Patients with Candidemia.
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Clsi m45 isolates. It should be noted, however, that these data are often clsi m45 by the design of clinical csli to systematically exclude patients whose isolates are thought to clzi drug resistant on the basis of clxi assumptions from the microbiological and pharmacokinetic data.
Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis. It is not widely known that Microbacterium resistens is intrinsically vancomycin resistant [ 20 ], and Leifsonia aquatica strains have diminished vancomycin susceptibility [ 19 ]. Antimicrobial activities against clai Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center — The CLSI previously described testing conditions for Campylobacter species but did not define interpretive breakpoints [ 12 ].